ASPEN PHARMACARE HOLDINGS LIMITED - Reminder of the release of Interim Results for the six months ended 31 December 2024 and Results Presentation

Reminder of the release of Interim Results for the six months ended 31 December 2024 and Results Presentation

ASPEN PHARMACARE HOLDINGS LIMITED
Incorporated in the Republic of South Africa
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
("Aspen")


REMINDER OF THE RELEASE OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2024 AND 
RESULTS PRESENTATION

Shareholders are advised that Aspen intends on releasing its results for the six months ended 31 December
2024 on Monday, 3 March 2025 via JSE SENS at 13:00pm (SAST, GMT+2), with a presentation to members of
the investment community, in-person, at The Westin Hotel, Cape Town and via webcast on Tuesday, 4 March
2025 at 08:30am (SAST, GMT+2).

All interested stakeholders are invited to watch the live webcast which can be accessed using the link
provided here: https://www.corpcam.com/Aspen04032025.

To attend in person, interested persons are requested to RSVP by following the link provided here:
https://aspenpharmaforms.com/view.php?id=31392 or through the invitation sent through The Vault
Exchange.

The slides accompanying the presentation will be available on the home page of the Aspen website
(www.aspenpharma.com) shortly before the commencement of the presentation on Tuesday, 4 March 2025.

A playback of the webcast will be made available on our website approximately 2 hours after the
presentation.



Durban
20 February 2025

Sponsor
Investec Bank Limited

Date: 20-02-2025 10:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.